Neochem Bio Solutions Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	77.51	19.27	10.73	-
Depreciation & Amortization	13.28	12.2	12.17	-
Loss (Gain) From Sale of Assets	-0.74	-	-	-
Other Operating Activities	51.33	29.67	22.56	-
Change in Accounts Receivable	-80.36	-25.77	9.57	-
Change in Inventory	-55.46	-32.79	-16.37	-
Change in Accounts Payable	21.97	6.93	-49.46	-
Change in Other Net Operating Assets	-1.56	-15.82	3.38	-
Operating Cash Flow	25.95	-6.31	-7.42	-
Capital Expenditures	-11.41	-83.85	-33.3	-
Sale of Property, Plant & Equipment	-	30.29	-	-
Investment in Securities	0	0.89	-	-
Other Investing Activities	-5.46	0.04	-0.21	-
Investing Cash Flow	-16.87	-52.63	-33.51	-
Short-Term Debt Issued	61.4	18.75	56.63	-
Long-Term Debt Issued	-	57.86	5.27	-
Total Debt Issued	61.4	76.61	61.9	-
Short-Term Debt Repaid	-22.57	-	-3.33	-
Long-Term Debt Repaid	-15.83	-	-	-
Total Debt Repaid	-38.39	-	-3.33	-
Net Debt Issued (Repaid)	23.01	76.61	58.57	-
Issuance of Common Stock	-	20	-	-
Other Financing Activities	-35.05	-34.65	-20.99	-
Financing Cash Flow	-12.04	61.95	37.57	-
Miscellaneous Cash Flow Adjustments	-	0.04	-0	-
Net Cash Flow	-2.96	3.05	-3.36	-
Free Cash Flow	14.54	-90.16	-40.72	-
Free Cash Flow Margin	1.73%	-14.72%	-8.45%	-
Free Cash Flow Per Share	1.24	-13.51	-7.70	-
Cash Interest Paid	35.05	29.59	21	-
Cash Income Tax Paid	8.7	-	2.79	-
Levered Free Cash Flow	-31.12	-87.73	-	-
Unlevered Free Cash Flow	-11.61	-72.03	-	-
Change in Working Capital	-115.42	-67.45	-52.88	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.